Bayer’s PRINCE Makes LLM‑Driven Drug Research Trustworthy at Scale
Bayer’s PRINCE platform shows how to turn LLMs into a production‑ready research assistant for drug discovery. The case study details orchestration, recovery, observability and human‑in‑the‑loop safeguards that keep the system trustworthy at scale. It proves agentic AI can cut data‑access time while meeting regulatory compliance.